|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.74 EUR | -0.11% |
|
+16.00% | -36.03% |
| Apr. 30 | Klarsen Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 15 | Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development | MT |
Klarsen reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 0.154421 million compared to EUR 0.084509 million a year ago. Net income was EUR 2.75 million compared to EUR 0.37673 million a year ago.
Basic earnings per share from continuing operations was EUR 0.83 compared to EUR 0.11 a year ago. Diluted earnings per share from continuing operations was EUR 0.83 compared to EUR 0.11 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.03% | 6.16M | |
| -13.19% | 191B | |
| +3.71% | 167B | |
| +5.09% | 158B | |
| +2.17% | 97.42B | |
| +48.98% | 92.57B | |
| +17.33% | 84.74B | |
| +1.97% | 76.34B | |
| -0.76% | 46.78B | |
| -35.11% | 43.24B |
KLARSEN 
